Year |
Citation |
Score |
2019 |
Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, et al. Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 29: 785-789. PMID 31618645 DOI: 10.1016/j.celrep.2019.09.089 |
0.32 |
|
2019 |
Luteijn RD, Zaver SA, Gowen BG, Wyman SK, Garelis NE, Onia L, McWhirter SM, Katibah GE, Corn JE, Woodward JJ, Raulet DH. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. 573: 434-438. PMID 31511694 DOI: 10.1038/S41586-019-1553-0 |
0.388 |
|
2018 |
Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, et al. Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 25: 3074-3085.e5. PMID 30540940 DOI: 10.1016/J.Celrep.2018.11.047 |
0.433 |
|
2018 |
Deng W, Lira V, Hudson TE, Lemmens EE, Hanson WG, Flores R, Barajas G, Katibah GE, Desbien AL, Lauer P, Leong ML, Portnoy DA, Dubensky TW. Recombinant promotes tumor rejection by CD8 T cell-dependent remodeling of the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America. PMID 30038013 DOI: 10.1073/Pnas.1801910115 |
0.402 |
|
2018 |
Desbien AL, Gauthier KS, Corrales L, Reiner G, Glickman LH, Katibah G, Hudson TE, Vu U, Surh NH, Francica B, Deng W, Kanne DB, Leong JJ, Ndubaku C, Metchette K, et al. Abstract 631: Intratumoral activation of STING with a synthetic cyclic dinucleotide elicits antitumor CD8 T-cell immunity that effectively combines with checkpoint inhibitors Cancer Research. 78: 631-631. DOI: 10.1158/1538-7445.Am2018-631 |
0.406 |
|
2017 |
Sivick KE, Surh NH, Desbien AL, Grewal EP, Katibah GE, McWhirter SM, Dubensky TW. Comment on "The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele". Journal of Immunology (Baltimore, Md. : 1950). 198: 4183-4185. PMID 28533276 DOI: 10.4049/Jimmunol.1700294 |
0.349 |
|
2016 |
McWhirter SM, Glickman LH, Desbien T, Gauthier KS, Kanne D, Kasibhatla S, Li J, Pferdekamper AC, Katibah G, Lemmens E, Corrales L, Leong M, Ndubaku C, Leong J, Sung L, et al. Abstract B020: STING activation in the tumor microenvironment using a synthetic human STING-activating cyclic dinucleotide induces potent antitumor immunity Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B020 |
0.458 |
|
2016 |
Glickman LH, Corrales L, Kanne DB, Kasibhatla S, Li J, Pferdekamper AMC, Gauthier KS, Katibah GE, Leong JJ, Sung L, Metchette K, Deng W, Desbien AL, Ndubaku C, Zheng L, et al. Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Sy39-02 |
0.467 |
|
2016 |
Glickman LH, Kanne DB, Kasibhatla S, Li J, Pferdekamper AC, Gauthier KS, Deng W, Desbien AL, Katibah GE, Leong JJ, Sung L, Metchette K, Ndubaku C, Zheng L, Cho C, et al. Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity Cancer Research. 76: 1445-1445. DOI: 10.1158/1538-7445.Am2016-1445 |
0.458 |
|
2015 |
Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo SR, Lemmens E, Banda T, Leong JJ, Metchette K, Dubensky TW, Gajewski TF. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Reports. 11: 1018-30. PMID 25959818 DOI: 10.1016/J.Celrep.2015.04.031 |
0.441 |
|
2015 |
Glickman LH, Kanne DB, Gauthier KE, Katibah GE, Leong JJ, Metchette K, Dubensky TW, McWhirter SM. Abstract 4272: Potentin situcancer immunotherapy with synthetic human STING-activating cyclic dinucleotides Cancer Research. 75: 4272-4272. DOI: 10.1158/1538-7445.Am2015-4272 |
0.467 |
|
2014 |
Katibah GE, Qin Y, Sidote DJ, Yao J, Lambowitz AM, Collins K. Broad and adaptable RNA structure recognition by the human interferon-induced tetratricopeptide repeat protein IFIT5. Proceedings of the National Academy of Sciences of the United States of America. 111: 12025-30. PMID 25092312 DOI: 10.1073/Pnas.1412842111 |
0.474 |
|
2013 |
Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L, René O, Katibah GE, Zhang L, Holmes MC, Doyon Y, Concordet JP, Giovannangeli C, Jasin M, Brunet E. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Research. 23: 1182-93. PMID 23568838 DOI: 10.1101/Gr.147314.112 |
0.352 |
|
2013 |
Katibah GE, Lee HJ, Huizar JP, Vogan JM, Alber T, Collins K. tRNA binding, structure, and localization of the human interferon-induced protein IFIT5. Molecular Cell. 49: 743-50. PMID 23317505 DOI: 10.1016/J.Molcel.2012.12.015 |
0.472 |
|
2009 |
Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, Katibah GE, Amora R, Boydston EA, Zeitler B, Meng X, Miller JC, Zhang L, Rebar EJ, Gregory PD, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotechnology. 27: 851-7. PMID 19680244 DOI: 10.1038/Nbt.1562 |
0.321 |
|
2008 |
Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE, Amora R, Hocking TD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Amacher SL. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nature Biotechnology. 26: 702-8. PMID 18500334 DOI: 10.1038/Nbt1409 |
0.301 |
|
Show low-probability matches. |